This latest book in the Management of Urology Series provides insight into how to appropriately manage patients undergoing pelvic robotic urological surgery for renal cancer. Extensive guidance is provided on how to perform a range of procedures including the retroperitoneal renal approach along with information on how to utilize the latest robots effectively. Cases are also presented on how to best manage complications associated with partial nephrectomy. Each chapter also contains learning objectives to assist the reader in extrapolating the key information covered. Robotic Surgery for Renal Cancer is an up-to-date overview of the latest techniques utilized in this field along with potential management strategies for these patients, making it a critical resource for urologists, oncologists, and specialist nurses.

Provides information on research based outcomes in robotic surgery Features a variety of cases on best practice when managing these patients Contains learning objectives in each chapter to reinforce key points

Autorentext

Sanchia Goonewardene qualified from Birmingham Medical School with Honours in Clinical Science and a BMedSc Degree in Medical Genetics and Molecular Medicine. She has a specific interest in academia during her spare time, with over 727 publications to her name with 2 papers as a number 1 most cited in fields (Biomedical Library), and has significantly contributed to the Urological Academic World - she has since added a section to the European Association of Urology Congress on Prostate Cancer Survivorship and Supportive Care and is an associate member of an EAU guidelines panel on Chronic Pelvic Pain. She has been the UK lead in an EAU led study on Salvage Prostatectomy. She has also contributed to the BURST IDENTIFY study as a collaborator.

Her background with research entails an MPhil, the work from which went on to be drawn up as a document for PCUK then, NICE endorsed. She gained funding from the Wellcome Trust for her Research Elective. She is an Alumni of the Urology Foundation, who sponsored a trip to USANZ trainee week, and has published several books.

She has supervised her first thesis with Kings College London and Guys Hospital, and is an Associate Editor with the Journal of Robotic Surgery, responsible as Urology Section Editor. She is an Editorial board member of the World Journal of Urology and was a Guest Editor for a Special Issue on Salvage Therapy in Prostate Cancer. She is a review board member for BMJ case reports. Additionally, she is on The International Continence Society Panel on Pelvic Floor Dysfunction, Good Urodynamic Practice Panel, is an ICS abstract reviewer and has been an EPoster Chair at ICS. More recently she has been an ICS Ambassador 2020 and is an ICS Mentor. She has chaired semi-live surgery at ERUS and presented her work as part of the Young Academic Urology Section at ERUS. More recently she has been an ICS Ambassador 2020 and is an ICS Mentor. She has chaired semi-live surgery at ERUS and presented her work as part of the Young Academic Urology Section at ERUS.

Professor Raj Persad, appointed in 1996, is a Consultant Urological Surgeon and Andrologist in Bristol. In his clinical role, he is one of the most experienced pelvic cancer surgeons in the UK and was one of the first in the UK to practice female neobladder reconstruction following cystectomy for invasive bladder cancer. He has subspecialised over many years in precise surgical techniques which improve both oncologic and functional outcomes. This includes techniques ranging from 1) the use of the Da Vinci Robot for performing Robot Assisted Laparoscopic Radical Prostatectomy, 2) High Intensity Focused Ultrasound for minimally invasive non-surgical treatment of prostate cancer and 3) Rectal Spacer and Fiducial Marker precision placement for optimizing the outcomes of Image Guided Radiotherapy for prostate cancer.

In the field of Diagnostics he has been one of the National Leads in developing the prostate pre-biopsy MRI pathway for patients with elevated PSA. This has optimized the accuracy of cancer diagnosis minimized clinical risk and sepsis associated with transrectal biopsy. He has developed to a fine art both cognitive transperineal biopsies of the prostate as well as Fusion Biopsy of the prostate. Professor Persad has been a National pioneer in minimally invasive techniques for the treatment of Symptomatic Benign Prostatic as an alternative to Transurethral Prostatectomy (TURP). These techniques include Urolift (prostatic urethral lift) procedure which he does under general or local anaesthetic depending on patient preference as well as REZUM, steam treatment of the prostate. He also treats BPH with Green Light Laser. All these techniques are offered by Professor Persad for BPH as well as traditional TURP if tablet therapy has failed or cannot be tolerated by the patient.

Professor Persad is also a National Authority in the treatment of Erectile Dysfunction. He practices optimum medical therapies for all male patients and has a large cohort of patients who are diabetic or who have had prostatectomy and in need of erectile function restoration. If conservative therapy fails with erectogenic pharmacotherapy or use of medical devices he can offer the insertion of state of the art penile prosthetic devices. Professor Persad also treats deformity due to Peyronies across a range of severity, offering therapeutic injection in its early phases and various types of surgical correction if this fails according to patient needs. Professor Persad has a 25 year experience in the restoration of fertility through microsurgical reversal of vasectomy and has some of the best results nationally. He also for more complex cases offers epididymo-vasovasostomy. In combination with the Bristol Centre for Reproductive Medicine, he will soon be offering male infertility procedures such as micro-TESE (testicular extraction of sperm) in order to optimize assisted conception techniques.

Academically, Prof Persad is involved in an extensive range of research with the Universities of Bristol, Pittsburgh, London and Oxford. These include the detection of early bladder and prostate cancer and novel imaging and treatment strategies for these diseases. He formerly led a team of researchers engaged in improving strategies for treatment of advanced prostate cancer in areas of hormonal treatment and immunotherapy (BPCRN). He has been Principal Investigator, Chief Investigator, and Collaborator in many National and International studies sponsored by the MRC, EORTC, CRUK, and NCRN. He has been a recipient of £4.5m research grants from UK bodies as well as the NIH USA, and has published over 300 scientific articles and 7 books in the field of Urology.

Together with Scientists and Clinicians in Bristol he is part of the productive BRC (Biomed Research Centre), which has a number of far-reaching clinical and scientific goals in the field of cancer and is Surgical Principle Investigator for the PreVent and Pre-Empt trials of lifestyle intervention in prostate cancer. He has an innovative research programme with Prof Chris Melhuish in Medical Robotics to enhance surgery and radiotherapy modalities with Robotic assistance.

In addition to his University and NHS Clinical commitments, he spends time visiting hospital units in the developing world (eg Tanzania), where he helps to train junior doctors and other healthcare professionals.

Dr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr. Albala was an endourology fellow at Washington University Medical Center under the direction of Ralph V. Clayman. He practiced at Loyola University Medical Center in Chicago and rose from the ranks of Instructor …